Neuraxpharm Enters Japanese Market
Follows Buccolam Deal With Takeda Last Year
Neuraxpharm has expanded its footprint outside of Europe with the launch of its first product in Japan, in the form of the Buccolam value-added midazolam product gained through a deal with Takeda.
